Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELBESTA vs CELEBREX in Rheumatoid Arthritis
NCT02780323Phase 4Completed
- Sponsor
- Dong-A ST
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of celecoxib in rheumatoid arthritis (RA) (2 arms), sponsored by Dong-A ST. Primary endpoint: Visual Analog Scale for Pain at 6 weeks. Started Nov 2015; status: completed.
02
Drugs
celecoxib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02780323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02780323.